Clinical Trials Browser

Phase 2/3 × Propranolol × 90 days × Clear all

NCT06798363 2026-03-16

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

Phase 2/3 Recruiting

Ulcer, Hemangioma, Capillary